Universal Ibogaine Inc.
IBOGF
$0.0177
$0.00084.73%
OTC PK
| 01/31/2025 | 10/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -16.80% | -22.97% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -16.80% | -22.97% | |||
| Cost of Revenue | -21.93% | -2.11% | |||
| Gross Profit | 177.88% | -113.63% | |||
| SG&A Expenses | -5.96% | 452.50% | |||
| Depreciation & Amortization | 6.45% | -17.16% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -18.10% | 8.99% | |||
| Operating Income | 19.92% | -160.96% | |||
| Income Before Tax | 15.64% | 54.20% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 15.64% | 54.20% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 15.64% | 54.20% | |||
| EBIT | 19.92% | -160.96% | |||
| EBITDA | 29.33% | -1,022.45% | |||
| EPS Basic | 12.50% | 61.90% | |||
| Normalized Basic EPS | 20.00% | -150.00% | |||
| EPS Diluted | 12.50% | 72.41% | |||
| Normalized Diluted EPS | 20.00% | -150.00% | |||
| Average Basic Shares Outstanding | 0.00% | 17.19% | |||
| Average Diluted Shares Outstanding | 0.00% | 17.19% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||